A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Hoffmann-La Roche
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
adult patients at least 18 years of age with moderate to severe active RA for at least 6 months;
inadequate response to current anti-rheumatic therapies, including MTX;
inadequate response or intolerance to treatment with 1 or more anti-TNF therapies within 1 year of entering study;
on stable MTX for at least 8 weeks before entering study;
patients of reproductive potential must be using reliable methods of contraception.
You may not be if
major surgery (including joint surgery) within 8 weeks before screening, or planned major surgery within 6 months after entering study;
women who are pregnant or breast-feeding.
Clareo Health | A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
